Dr. Gene Burton has more than 25 years of biotechnology industry experience, working in various roles in biotechnology company management, including recombinant drug process and product development and as well as being a seasoned recombinant protein chemist. He is currently active in biotechnology consulting for CMC phases of recombinant product development. Before taking up consulting, he was VP of Product Development and Process Sciences at Receptor BioLogix, Inc., a startup company in the oncology space working on the research and development of receptor extracellular domain-IgG fusion proteins of the HER family system of receptors. Prior to the role at Receptor BioLogix, he spent over 17 years at Genentech, Inc. and 5 years at Bayer Corporation, primarily focused on recombinant protein purification, process design , other aspects of biologics CMC activities and manufacturing implementation at scale, for pre-IND, IND and BLA drug candidates. As an adviser to Celltheon, Dr. Burton regularly advises the team on various aspects of downstream processing, CMC related development and other aspects of drug development. Dr. Burton's extensive knowledge of the biotech industry has made him an invaluable part of the Celltheon team.